Table 1.
Patients and CAA Characteristics Considered in the Risk Factor Analysis for Cardiac Complications and Outcomes
| Risk Factors |
|---|
| Age at KD |
| Sex |
| Type of KD (complete/incomplete) |
| Arthritis at diagnosis |
| Laboratory values during acute phase |
| Hemoglobin, g/L |
| Hematocrit, % |
| ESR, mm/h |
| White blood cell count, ×109/L |
| Platelets, ×109/L |
| Albumin, g/L |
| C‐reactive protein, mg/L |
| Red blood cell count, ×1012/L |
| Aspartate transaminase, U/L |
| Alanine aminotransferase, U/L |
| Duration of fever before IVIGs |
| Total duration of fever |
| IVIG treatment |
| No. of IVIG doses |
| Intravenous steroids in the acute phase |
| Oral steroids in the acute phase |
| Infliximab in the acute phase |
| Any use of nonsteroidal anti‐inflammatory drugs in the acute phase |
| Coronary artery branch |
| Maximum coronary artery Z score |
| Involvement of the LAD/LMCA/LCX bifurcation |
| Aneurysm architecture |
| Aneurysm location within coronary branch |
| Aneurysm shape |
| Aneurysm width to height ratio |
| Aneurysm estimated area |
CAA indicates coronary artery aneurysm; ESR, erythrocyte sedimentation rate; IVIG, intravenous immunoglobulin; KD, Kawasaki disease; LAD, left anterior descending artery; LCX, left circumflex artery; and LMCA, left main coronary artery.